Diagnosis
Î The AGA suggests that patients with pancreatic cysts <3 cm
without a solid component or a dilated pancreatic duct undergo
MRI for surveillance in 1 year and then every 2 years for a
total of 5 years if there is no change in size or characteristics.
(Conditional; Very Low Quality of Evidence)
Î The AGA suggests that pancreatic cysts with at least 2 high-
risk features, such as size ≥3 cm, a dilated main pancreatic
duct, or the presence of an associated solid component, should
be examined with EUS-FNA. (Conditional; Very Low Quality of
Evidence)
Î The AGA suggests that patients without concerning EUS-FNA
results should undergo MRI surveillance after 1 year and
then every 2 years to ensure no change in risk of malignancy.
(Conditional; Very Low Quality of Evidence)
Î The AGA suggests that significant changes in the
characteristics of the cyst, including the development of a
solid component, increasing size of the pancreatic duct, and/
or diameter ≥3 cm, are indications for EUS-FNA. (Conditional;
Very Low Quality of Evidence)
